NCT04385134

Brief Summary

Neonates could be infected by non-polio enterovirus easily. Some of the neonates may develop fatal complications within one week. The objective of this study were as following: 1.To understand the composition and epidemiological characteristics of enterovirus infection in pregnant women in some areas of China; 2.To understand the transmission from mother to their neonates; 3.To understand the pathogenic spectrum composition, epidemiological characteristics and clinical characteristics of enterovirus infection in neonates; 4.To understand the genetic variation and changes of enteroviruses; 5.To establish a quality management system for maternal and neonatal enterovirus laboratory testing and monitoring.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 12, 2020

Completed
8 days until next milestone

Study Start

First participant enrolled

May 20, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2021

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2022

Completed
Last Updated

May 12, 2020

Status Verified

May 1, 2020

Enrollment Period

1 year

First QC Date

May 8, 2020

Last Update Submit

May 8, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Detection of enterovirus

    Detection of the rate of enterovirus infection and identify the genotype of enterovirus.

    42 days

Secondary Outcomes (1)

  • Detection of antibodies of enterovirus

    42 days

Study Arms (3)

General parturient

Observe the enterovirus infection in general parturients and their neonates.

Other: No intervention

Puerpera with fever

Observe the enterovirus infection in puerpera with fever and their neonates.

Other: No intervention

Febrile newborns

Observe the enterovirus infection in neonates

Other: No intervention

Interventions

No intervention

Febrile newbornsGeneral parturientPuerpera with fever

Eligibility Criteria

AgeUp to 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Three population would be studied. 1. General parturient; 2. Puerpera with fever; 3, Febrile newborns.

You may qualify if:

  • \. General parturient: on the first day of the third week of each month, all parturients and their newborns admitted to the hospital (day shift 8:00-18:00) within that day; 2. Puerpera with fever: all puerperas with fever (body temperature \>=37.5 degree C) and their newborns were included in summer and autumn (from May); 3. Febrile newborns: those included in summer and autumn (from May) with the following clinical characteristics: fever \>=37.5 degree C, lasting for more than one day. And sign the informed consent form with the consent of the guardian.

You may not qualify if:

  • \. Pregnant women with urinary tract infection, chorioamnionitis and bacterial infection; 2. Puerpera with fever due to urinary tract infection, chorioamnionitis and bacterial infection; 3. Newborns infected with other pathogens.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bayi Children's Hospital, Seventh Medical Center, PLA general hospital

Beijing, Beijing Municipality, 100700, China

Location

Central Study Contacts

Zhichun Feng, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2020

First Posted

May 12, 2020

Study Start

May 20, 2020

Primary Completion

May 20, 2021

Study Completion

December 25, 2022

Last Updated

May 12, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations